Physician profile
Barry J Brownstein
NPI 1144403023
$864.24
in general payments reported to CMS, 2019-2025
13 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.00 · 2021: $275 · 2022: $110 · 2023: $140 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $252.54 | 2025 | |
| Abbott Laboratories | $116.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $114.70 | 2021 | |
| Sanofi-Aventis U.S. LLC | $91.11 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.07 | 2022 | |
| Boston Scientific Corporation | $52.22 | 2025 | Cds - Mct/Cem Monitoring |
| Vital Connect, INC | $49.05 | 2023 | Vitalpatch Rtm |
| Bardy Diagnostics, INC. | $35.00 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $33.80 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $26.94 | 2022 | |
| Kestra Medical Technology Services, INC. | $13.49 | 2025 | Assure Wcd |
| Pfizer INC. | $12.06 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Brownstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.